FUTURE of PHASE 1, 2, and 3 TRIALS
July 20011 FUTURE of PHASE 1, 2, and 3 TRIALS Philip Colangelo, Pharm.D., Ph.D. Office of Clinical Pharmacology & Biopharmaceutics FDA / CDER.